Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion

NCT02432105 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT02432105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02432105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
June 25, 2015
Completion date
June 15, 2016
Enrollment
470 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

otitis media recurrent, otitis media with effusion in children